We demonstrate that anti-TNF Ab–treated patients with IBD exhibit altered GC outputs in response to SARS-CoV-2 mRNA vaccination, characterized by reduced SHM and a lower frequency of S-specific MBCs. Here, TNF is linked to inflammatory bowel disease.